FETOMATERNAL MEDICINE
FRIDAY, NOVEMBER 25

08:30-10:00

A PREIS SCHOOL ACADEMY SESSION

HALL C
Capsule Progesterone (and not progestins) has shown multifaceted roles in pregnancy and recent RCTS and metanalysis have confirmed a role of micronised progesterone in appropriate dosage and timing to prevent recurrent miscarriage and preterm birth and manage threatened miscarriage.
Chairperson Zion Ben Rafael, Israel
 08:30-08:35 Introduction
Zion Ben Rafael, Israel
08:35-08:50 A narrative story of progesterone and progestins
Paul Piette, Belgium
08:50-09:15 Sporadic and recurrent miscarriage: Preventive tools
Adam Duvall, UK
09:15-09:35 Preterm birth: Prediction and prevention
Gerard Visser, Netherlands
 09:35-09:55 Q&A
 09:55-10:00 Conclusion

 

10:00-10:20 Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50

HOT CONTROVERSIES

HALL C
Capsule
Chairpersons Basky Thilaganathan, UK
Amir Aviram, Canada
10:20-10:50

10:20
10:30
10:40

Debate: cfDNA testing
For Universal cfDNA testing by genome wide approach: Mireille Bekker, Netherlands
Against genome wide cfDNA testing: Tina Buchholz, Germany
Discussion
10:50-11:05 Stem cells in obstetrics and gynecology
Wolfgang Holzgreve¸ Germany
11:05-11:20 Fetal surgery: Learning curve
Luc JoyeuxBelgium
 11:20-11:35 TTTS +/- sFGR: long-term effects
Jeanine van Klink, Netherlands
11:35-11:50 Treatment of Rh disease
Joanne VerweijNetherlands

 

11:50-12:00 Break

 

12:00-13:30 HYPERTENSIVE DISORDERS HALL C
Capsule Hypertensive disorders are associated with underlying placental and maternal changes, and are associated with endothelial dysfunction and vasospasm, leading to placental insufficiency and serious consequences for the mother and infant.
Chairpersons Gerard Visser, Netherlands
Arie Franx, Netherlands
12:00-12:20 What is new and controversial In Hypertension in pregnancy?
Asma Khalil, UK
12:20-12:45 The SNAP-HT trial: optimal postpartum BP control
Paul Leeson, UK
12:45-13:05 Does birth cure preeclampsia?
Basky Thilaganathan, UK
13:05-13:30 New treatments to prevent complications
Emmanuel Attali, Israel

 

13:30-14:30  Lunch break,  moderated e-posters and visit the exhibition Exhibition Area

 

14:30-15:30 AN ARTIFICIAL WOMB FOR EXTREMELY PRETERM INFANTS HALL C
Capsule Is it possible and is it ethical to maintain alive an extremely premature baby?
Chairpersons Guid Oei, Netherlands
Mats BrännströmSweden
14;30-14:50 An artificial womb for extremely preterm infants
Guid Oei, Netherlands
14:50-15:10 Development of a liquid-based incubator for extremely premature infants
Mark Schöberer, Germany
15:10-15:30 Ethical aspects of the development of a liquid based incubator
Joanne Verweij, Netherlands
15:30-16:30 MATERNAL VACCINATION
Capsule Offering maternal vaccination when its available, when do we reject the idea?
Chairpersons Kitty Bloemenkamp, Netherlands
Mireille Bekker, Netherlands
15:30-15:50 Efficacy and safety of available maternal vaccinations: Update on available literature (syst review)
Odette de Bruin, Netherlands
Emily Phijffer, Netherlands
15:50-16:00 Maternal vaccinations: EMA’s perspective
Corinne de Vries, Netherlands
16:00-16:10 Maternal vaccinations: Patients perspective (Infant protection through maternal immunization, why do women accept or don’t accept maternal vaccinations
Flor M. Munoz, USA
16:10-16:30 Panel Discussion

 

16:30-16:50  Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 GDM AND PRE-GDM HALL C
Capsule
Chairpersons Yariv Yogev, Israel
Gerard Visser, Netherlands
16:50-17:15 How to define well glycemic control
Yariv Yogev, Israel  
17:15-17:35 GDM in twins – More harm than a disease?
Nir Melamed, Canada
17:35-18:00 Pragmatic approach for GDM diagnosis
Eran AshwalCanada
18:00-18:20 What is the best pharmacological therapy for GDM? (Metformin\glyburide\insulin?)
Yariv Yogev, Israel

 

Skip to content